Breaking News Instant updates and real-time market news.

WFC

Wells Fargo

$43.78

-0.5034 (-1.14%)

, MYL

Mylan

$38.12

-0.35 (-0.91%)

12:43
10/03/16
10/03
12:43
10/03/16
12:43

Clinton to mention Mylan, Wells Fargo as 'bad corporate actors,' Reuters says

While campaigning in Ohio on Monday, U.S. presidential candidate Hillary Clinton is expected to disclose a plan to make it easier for consumers to take legal action against "bad corporate actors," citing companies Wells Fargo (WFC) and Mylan (MYL) says Reuters, citing a campaign official. Reference Link

WFC

Wells Fargo

$43.78

-0.5034 (-1.14%)

MYL

Mylan

$38.12

-0.35 (-0.91%)

  • 07

    Oct

  • 23

    Oct

  • 28

    Mar

WFC Wells Fargo
$43.78

-0.5034 (-1.14%)

09/28/16
DBAB
09/28/16
UPGRADE
Target $11.5
DBAB
Buy
Huntington Bancshares upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Matt O'Connor upgraded Huntington Bancshares to Buy saying the 15% pullback in the shares since the FirstMerit (FMER) deal was announced is overdone. The analyst views industry-wide concerns surrounding consumer indirect auto lending as overblown and he raised his price target for Huntington shares to $11.50 from $10.50. Going into the Q3 results for U.S. banks, O'Connor likes JPMorgan (JPM) and Wells Fargo (WFC) and is cautious on Fifth Third (FITB).
09/22/16
DBAB
09/22/16
NO CHANGE
Target $50
DBAB
Buy
Wells Fargo price target lowered to $50 from $59 at Deutsche Bank
Deutsche Bank analyst Matt O'Connor lowered his price target for Wells Fargo to $50 saying it's "tough to argue for much upside in the near term." The analyst, however, believes that over the next year, Wells Fargo's issues should subside and its "attractive valuation should be more relevant." After laying out the bull and bear thesis on the shares, O'Connor sees 5%-12% relative upside in the name. He keeps a Buy rating on Wells Fargo.
09/21/16
09/21/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Neutral from Overweight at JPMorgan with analyst Vivek Juneja saying the "tough" Senate hearings and "mounting public scrutiny" will likely result in additional investigations that could pressure expenses. 2. Skechers (SKX) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Jay Sole saying he believes consumers shift towards pure fashion styles and away from athletic footwear is causing Skechers to adjust assortment, resulting in slower sales growth. 3. American Airlines (AAL) downgraded to Market Perform from Outperform at Raymond James analyst Savanthi Syth citing relative valuation and lowered estimates to reflect the new mechanics contract. 4. Boston Beer (SAM) downgraded to Underperform from Market Perform at Cowen with analyst Vivien Azer citing its string of disappointing monthly Nielsen data and structural headwinds to the company's core assets, which present meaningful earnings risk. 5. Children's Place (PLCE) downgraded to Neutral from Overweight at Piper Jaffray with analyst Stephanie Wissink saying the firm's recent survey of moms pointed to a "step down" in mindshare. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/21/16
JPMS
09/21/16
DOWNGRADE
Target $48
JPMS
Neutral
Wells Fargo downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Vivek Juneja downgraded Wells Fargo to Neutral saying the "tough" Senate hearings and "mounting public scrutiny" will likely result in additional investigations that could pressure expenses. There is "significant uncertainty about how much some issues will cost and how long they will take," Juneja tells investors in a research note. He believes Wells will need to spend a lot more on litigation and that its revenues "will likely face some slowdown in growth." Juneja cut his price target for the shares to $48 from $53.50. Wells Fargo closed yesterday up 55c to $46.56.
MYL Mylan
$38.12

-0.35 (-0.91%)

09/30/16
LEER
09/30/16
NO CHANGE
Target $45
LEER
Outperform
Mylan price target cut to $45 on lower EpiPen estimates at Leerink
Leerink analyst Jason Gerberry lowered his EpiPen sales forecasts by 33-45% from 2017-2021 in light of recent company updates, including its plan to launch an authorized generic of the emergency treatment later this year. While Mylan "appears on the right side of the law" regarding the latest Medicaid rebate controversy, Gerberry believes investors should consider the risk of a future settlement related to the issue. He cut his price target on Mylan shares to $45 from $55, but keeps an Outperform rating on the stock as he sees cash flows being sufficient to justify the current price.
09/23/16
BERN
09/23/16
NO CHANGE
BERN
Mylan generic Epipen to lower EPS by about 10%, says Bernstein
Bernstein analyst Aaron Gal estimates that Mylan's decision to introduce a generic version of its EpiPen will create a drag of about 10% on its EPS. After viewing the Congressional hearings on the device, Gal continues to believe that a competitor to EpiPen will hit the market before the end of 2018. He keeps a $60 price target and Outperform rating on Mylan.
09/22/16
ARGS
09/22/16
NO CHANGE
ARGS
Mylan weakness creates good entry point, says Argus
After Mylan's stock fell 17% over the last month, Argus analyst Jacob Kilstein thinks that the stock has reached an attractive entry point, He says that the company's new generic EpiPen will cannibalize branded sales but should help it beat upcoming generic competitors. He thinks that the stock is undervalued and keeps a Buy rating on the stock.
09/22/16
LEER
09/22/16
NO CHANGE
LEER
Outperform
No tangible outcomes likely to result from Mylan EpiPen hearing, says Leerink
Leerink analyst Jason Gerberry believes no tangible outcomes are likely to result from the House Committee Hearing on Mylan's EpiPen. Nonetheless, the analyst highlights that CEO Heather Bresch stated at the hearing that the company has invested in a new formulation of EpiPen, with a 24-month shelf life versus the current 12-month. Gerberry believes this is a relatively modest benefit and says he is skeptical the line extension will be able to preserve meaningful share if/when an AB-rated generic gets approved. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

DLTH

Duluth Holdings

$37.04

3.09 (9.10%)

16:58
12/08/16
12/08
16:58
12/08/16
16:58
Hot Stocks
Breaking Hot Stocks news story on Duluth Holdings »

Duluth Holdings down over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

CFR

Cullen/Frost

$88.38

1.92 (2.22%)

16:55
12/08/16
12/08
16:55
12/08/16
16:55
Syndicate
Breaking Syndicate news story on Cullen/Frost »

Cullen/Frost files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

DTEA

DAVIDsTEA

$9.30

0.15 (1.64%)

16:49
12/08/16
12/08
16:49
12/08/16
16:49
Hot Stocks
DAVIDsTEA appoints Christine Bullen interim president and CEO »

As previously announced,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

ISIL

Intersil

$22.25

0.05 (0.23%)

16:49
12/08/16
12/08
16:49
12/08/16
16:49
Hot Stocks
Intersil stockholders approve merger proposal with Renesas Electronics »

Intersil stockholders…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

DTEA

DAVIDsTEA

$9.30

0.15 (1.64%)

16:47
12/08/16
12/08
16:47
12/08/16
16:47
Earnings
DAVIDsTEA sees FY16 EPS C35c-C40c »

Sees FY16 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

TEL

TE Connectivity

$70.60

0.14 (0.20%)

16:45
12/08/16
12/08
16:45
12/08/16
16:45
Hot Stocks
TE Connectivity raises quarterly dividend to 40c per share from 37c »

TE Connectivity's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLTH

Duluth Holdings

$37.04

3.09 (9.10%)

16:41
12/08/16
12/08
16:41
12/08/16
16:41
Earnings
Duluth Holdings sees FY16 adjusted EBITDA $34M-$38M »

Seees FY16 GAAP EPS in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

16:39
12/08/16
12/08
16:39
12/08/16
16:39
General news
Fed Balance Sheet Level data reported »

Week of 12/7 Fed Balance…

16:39
12/08/16
12/08
16:39
12/08/16
16:39
General news
Money Supply M2 Weekly Change data reported »

Week of 11/28 Money…

ENZ

Enzo Biochem

$7.48

0.2 (2.75%)

, BDX

Becton Dickinson

$163.64

-0.35 (-0.21%)

16:38
12/08/16
12/08
16:38
12/08/16
16:38
Earnings
Enzo Biochem reports Q1 adjusted EPS (3c), one estimate (5c) »

Reports Q1 revenue…

ENZ

Enzo Biochem

$7.48

0.2 (2.75%)

BDX

Becton Dickinson

$163.64

-0.35 (-0.21%)

RHHBY

Roche

$27.08

-0.36 (-1.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CNS

Cohen & Steers

$37.23

0.48 (1.31%)

16:37
12/08/16
12/08
16:37
12/08/16
16:37
Hot Stocks
Cohen & Steers reports AUM of $56.5B as of November 30 »

Cohen & Steers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AWK

American Water

$73.05

0.39 (0.54%)

16:37
12/08/16
12/08
16:37
12/08/16
16:37
Hot Stocks
NJ American Water to invest $3.6M in Somerset County »

New Jersey American Water…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DEI

Douglas Emmett

$38.61

0.25 (0.65%)

16:34
12/08/16
12/08
16:34
12/08/16
16:34
Hot Stocks
Douglas Emmett increases quarterly cash dividend to 23c per share »

Douglas Emmett has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRIX

IRIDEX

$15.51

0.61 (4.09%)

16:34
12/08/16
12/08
16:34
12/08/16
16:34
Syndicate
IRIDEX announces offering of common stock, no amount given »

IRIDEX expects to use the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BURL

Burlington Stores

$88.47

0.47 (0.53%)

, BLK

BlackRock

$390.33

12.81 (3.39%)

16:33
12/08/16
12/08
16:33
12/08/16
16:33
Hot Stocks
Frank Cooper III resigns from Burlington Stores board of directors »

Burlington Stores (BURL)…

BURL

Burlington Stores

$88.47

0.47 (0.53%)

BLK

BlackRock

$390.33

12.81 (3.39%)

TJX

TJX

$77.98

-0.21 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STBZ

State Bank Financial

$26.90

0.51 (1.93%)

16:33
12/08/16
12/08
16:33
12/08/16
16:33
Hot Stocks
State Bank Financial reports FDIC approval for previously announced transaction »

State Bank Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MED

Medifast

$40.65

0.86 (2.16%)

16:32
12/08/16
12/08
16:32
12/08/16
16:32
Hot Stocks
Medifast raises quarterly dividend 28% to 32c per share »

Medifast announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

BEN

Franklin Resources

$42.02

1.4 (3.45%)

16:32
12/08/16
12/08
16:32
12/08/16
16:32
Hot Stocks
Franklin Resources reports month-end AUM of $714.4B »

Franklin Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APPY

Venaxis

$3.95

-0.28 (-6.62%)

16:32
12/08/16
12/08
16:32
12/08/16
16:32
Hot Stocks
Venaxis changing name and NASDAQ ticker symbol »

Venaxis has changed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECL

Ecolab

$119.61

0.8 (0.67%)

16:31
12/08/16
12/08
16:31
12/08/16
16:31
Hot Stocks
Ecolab raises quarterly dividend 6% to 37c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

16:30
12/08/16
12/08
16:30
12/08/16
16:30
Options
Preliminary option volume of 19.3M today »

Preliminary option volume…

BBRY

BlackBerry

$7.83

0.2 (2.62%)

16:27
12/08/16
12/08
16:27
12/08/16
16:27
Hot Stocks
BlackBerry unveils mobile-security platform for the enterprise of things »

BlackBerry unveiled its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

MCC

Medley Capital

16:25
12/08/16
12/08
16:25
12/08/16
16:25
Earnings
Medley Capital reports Q4 EPS 23c, consensus 22c »

Reports Q4 net asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

TAHO

Tahoe Resources

$10.01

-0.03 (-0.30%)

, BLK

BlackRock

$390.33

12.81 (3.39%)

16:24
12/08/16
12/08
16:24
12/08/16
16:24
Hot Stocks
Breaking Hot Stocks news story on Tahoe Resources, BlackRock »

BlackRock cuts passive…

TAHO

Tahoe Resources

$10.01

-0.03 (-0.30%)

BLK

BlackRock

$390.33

12.81 (3.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APTS

Preferred Apartment

$13.80

-0.09 (-0.65%)

16:23
12/08/16
12/08
16:23
12/08/16
16:23
Recommendations
Preferred Apartment analyst commentary  »

Preferred Apartment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.